U. Oltmanns (Heidelberg, Germany), A. Xaubet (Barcelona, Spain), E. Puxeddu (Rome, Italy), H. Collard (San Francisco, United States of America)
18F-FDG (fluorodeoxyglucose) uptake in focal organizing pneumonia mimicking bronchial carcinoma
A. Baha, F. Yildirim, N. Kokturk, U. O. Akdemir, S. Demircan (Ankara, Turkey)
|  |
Diagnostic value of video-assisted thoracoscopic lung biopsy on diagnosis of diffuse parenchymal lung dissease
A. S. Bayram, H. Melek, M. M. Erol, F. Coskun, E. U. Akyildiz, C. Gebitekin (Bursa, Turkey)
|  |
Use of acetylcysteinein the treatment of patients with exogenic allergic alveolitis (EAA)
N. Makaryants, L. Lepekha, E. Shmelev (Moscow, Russian Federation)
| |
Unusual multisystemic relapse of sarcoidosis after corticosteroids withdrawal
M. Sponholz Araujo, D. Antunes Silva Pereira, B. Guedes Baldi, C. Salim Gonçalves Freitas, C. Madeira Padovesi, R. Adib Kairalla, C. Roberto Ribeiro Carvalho (São Paulo, Brazil)
| |
Anti-inflammatory therapy for sarcoidosis patients
V. Romanov, S. Shelukhina, E. Shmelev (Moscow, Russian Federation)
| |
Influenza vaccine-induced ILD
P. Balbo, F. Patrucco, A. Lombi, R. Nicali (Novara, Italy)
| |
Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
F. Bonella, T. Wessendorf, U. Costabel (Essen, Germany)
| |
Myositis-associated interstitial pneumonia (MaIP): Autoantibody associations in patients presenting to pulmonologists and rheumatologists
S. Agarwal, E. Helm, S. C. H. Smith, S. Dubey, F. Woodhead (Coventry, United Kingdom)
| |
Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
M. Tanaka, M. Arita, H. Tachibana, T. Ishida, T. Nakazawa (Kurashiki, Japan)
| |
Histopathological findings of biopsies from patients with extrinsic allergic alveolitis (hipersensitivity pneumonia) in subacute or chronic phase
M. Salinas, R. Fritz, M. Meneses, J. C. Diaz, J. C. Rodriguez, M. Florenzano, A. Undurraga (Santiago, Chile)
| |
Pulmonary involvement in Moldova lupus study
C. Mariana, M. N. Lucia, S. Victoria, M. Minodora, C. Elena, A. Codrina (Chisinau, Republic Of Moldova; Iasi, Romania)
| |
Thanatogenesis of HIV-associated tuberculosis in penitentiary establishments of Belarus
P. Kryvanos, I. Ragulina, A. Grinevich, V. Akulow (Minsk, Belarus)
| |
Sleep-disordered breathing in idiopathic pulmonary fibrosis
M. Vennelle, P. MacFarlane, M. McKinley, J. Simpson, N. Hirani, R. Riha (Edinburgh, United Kingdom)
| |
Differences in chest HRCT between smoking and non-smoking rheumatoid arthritis patients with abnormal spirometry
A. Kawassaki, M. Kawassaki, D. Pereira, O. Dias, C. Carvalho, R. Kairalla (Sao Paulo, Brazil)
| |
What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays
A. Kempisty, B. Bialas-Chromiec, D. Borkowska, J. Kus (Warsaw, Poland)
| |
Main features of cytokine profile in serum and bronchoalveolar lavage fluid in patients with recurrent sarcoidosis
N. Demyanenko, V. Romanov, S. Sheluhina, E. Shmelev (Moscow, Russian Federation)
| |
Clinical and immunological parameters in patients with newly diagnosed sarcoidosis
N. Demyanenko, V. Romanov, S. Sheluhina, E. Shmelev, O. Lovacheva, M. Averbach (Moscow, Russian Federation)
| |
Median survival in unselected patients with idiopathic pulmonary fibrosis in the United Kingdom
W. Jamal, C. Wottons, G. Mirani, N. Foley (Bath, United Kingdom; Wynnewood, United States Of America)
| |
Smoking status and long term clinical outcome in patients with pulmonary Langerhans cell histiocytosis
C. Sugimoto, T. Arai, M. Kitaichi, M. Akira, A. Hirooka, S. Minomo, S. Hayashi, Y. Inoue (Sakai, Japan)
| |
Ultra-low dose CT in the assessment of diffuse lung disease: Comparison with conventional images
J. Gruden, P. Panse, M. Gotway (Phoenix, United States Of America)
| |